STING1 and neoplasm: While the importance of STING signaling in priming antitumor immunity is well established, less is known about the precise contributions of STING activation in the cells comprising the tumor and TME (i.e., neoplastic cells, immune cells, and stroma/vasculature) to antitumor immunity.